Investorideas.com

Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS




Share on StockTwits

CSE Biotech Listing - Awakn Life Sciences Corp. (CSE: AWKN)

 

February 9, 2024 (Investorideas.com Newswire) The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 51 million people in the US and key European markets and 285 million people globally for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.

________________________

Les actions ordinaires d'Awakn Life Sciences Corp. ont été approuvées pour leur inscription au CSE.

Les documents de cotation et d'information seront disponibles sur www.thecse.com à la date de négociation.

Awakn Life Sciences Corp. est une société de biotechnologie au stade clinique qui développe des traitements médicamenteux contre la dépendance. Awakn se concentre à court terme sur les troubles liés à la consommation d'alcool (AUD), une maladie qui touche environ 51 millions de personnes aux États-Unis et sur les principaux marchés européens et 285 millions de personnes dans le monde pour laquelle les normes de soins actuelles sont inadéquates. Notre objectif est de fournir des thérapies révolutionnaires aux toxicomanes qui en ont désespérément besoin et notre stratégie est axée sur la commercialisation de notre pipeline de R&D sur plusieurs canaux.


The Exchange is accepting Market Maker applications for AWKN. Please email: Trading@theCSE.com

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l'information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l'adresse: Listings@thecse.com

Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more...


Check out Investorideas.com listing on the CSE service provider list. We offer discounts to CSE listed stocks!

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004; the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/

More Info:


Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp


That's all it takes to get an article published on Investor Ideas - Learn More





BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on Investorideas.com